Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Dexamethasone and Lower Extremity Block Duration

Phase 4

Terminated

Conditions: Analgesia Duration

Interventions: Drug: Dexamethasone
Drug: Bupivacaine

First Posted Date: 2012-12-27

Last Posted Date: 2017-06-27

Lead Sponsor: University of Chicago

Target Recruit Count: 4

Registration Number: NCT01756586

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Effect of Dexamethasone on Duration of Lower Extremity Blocks With Bupivacaine in Subjects Having ACL Repair

Phase 4

Terminated

Conditions: Duration of Pain Relief

Interventions: Drug: dexamethsone
Drug: Bupivacaine

First Posted Date: 2012-12-27

Last Posted Date: 2019-05-14

Lead Sponsor: University of Chicago

Target Recruit Count: 2

Registration Number: NCT01756560

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Thirty Million Words Project: A Feasibility Trial

Not Applicable

Completed

Conditions: Parental Language Behaviors

Interventions: Behavioral: LENA Linguistic Feedback Reports
Behavioral: Childhood Nutrition Education
Behavioral: Home Visiting Educational Session

First Posted Date: 2012-12-21

Last Posted Date: 2013-09-05

Lead Sponsor: University of Chicago

Target Recruit Count: 40

Registration Number: NCT01754077

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Project ASPIRE Efficacy Pilot: Achieving Superior Parental Involvement for Rehabilitative Excellence

Not Applicable

Completed

Conditions: Parental Language Behaviors

Interventions: Behavioral: Linguistic Feedback Report
Behavioral: EI-As-Usual
Behavioral: Multimedia Education Sessions

First Posted Date: 2012-12-20

Last Posted Date: 2016-06-03

Lead Sponsor: University of Chicago

Target Recruit Count: 41

Registration Number: NCT01753661

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Double-Blind Treatment of Major Depressive Disorder With Vilazodone

Phase 2

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Vilazodone
Drug: Citalopram

First Posted Date: 2012-12-05

Last Posted Date: 2023-02-23

Lead Sponsor: University of Chicago

Target Recruit Count: 79

Registration Number: NCT01742832

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Network Supported Engagement In HIV Care

Not Applicable

Completed

Conditions: HIV
Patient Acceptance of Health Care

Interventions: Other: Supportive Care

First Posted Date: 2012-11-15

Last Posted Date: 2017-01-20

Lead Sponsor: University of Chicago

Target Recruit Count: 105

Registration Number: NCT01726712

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Effect of Nasaleze on Nasal Challenge With Allergen

Not Applicable

Terminated

Conditions: Allergic Rhinitis

Interventions: Drug: Nasaleze Spray
Other: Placebo spray
Biological: Allergen

First Posted Date: 2012-11-07

Last Posted Date: 2017-01-02

Lead Sponsor: University of Chicago

Target Recruit Count: 14

Registration Number: NCT01723397

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Drug Effects on Preference and Reward

Completed

Conditions: Drug Addiction

Interventions: Behavioral: Pairing condition

First Posted Date: 2012-11-06

Last Posted Date: 2013-09-05

Lead Sponsor: University of Chicago

Target Recruit Count: 103

Registration Number: NCT01722006

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

Completed

Conditions: Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate
Mucinous Ductal Breast Carcinoma
Central Nervous System Metastases
Invasive Ductal Breast Carcinoma
Recurrent Breast Cancer
Invasive Lobular Breast Carcinoma With Predominant in Situ Component
Lobular Breast Carcinoma in Situ
Papillary Ductal Breast Carcinoma
Invasive Ductal Breast Carcinoma With Predominant Intraductal Component
Invasive Lobular Breast Carcinoma

Interventions: Radiation: hyperfractionated radiation therapy
Other: laboratory biomarker analysis
Radiation: stereotactic radiosurgery

First Posted Date: 2012-10-15

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 4

Registration Number: NCT01706432

Locations: 🇺🇸
University of Chicago, North Chicago, Illinois, United States

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Phase 1

Terminated

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: capecitabine
Drug: celecoxib
Other: pharmacological study
Other: laboratory biomarker analysis
Other: pharmacogenomic studies

First Posted Date: 2012-10-12

Last Posted Date: 2018-05-30

Lead Sponsor: University of Chicago

Target Recruit Count: 21

Registration Number: NCT01705106

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy